Stocklytics Platform
Asset logo for symbol RPRX
Royalty Pharma PLC
RPRX63
$28.14arrow_drop_down0.67%-$0.19
Asset logo for symbol RPRX
RPRX63

$28.14

arrow_drop_down0.67%

Performance History

Chart placeholder
Key Stats
Open$28.23
Prev. Close$28.33
EPS1.78
Next Earnings DateDec 13, 2024
LOWHIGH
Day Range28.05
28.48
52 Week Range25.20
31.65
Ratios
EPS1.78

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Correlated Companies

Price$857.46
Perf. (24h)
arrow_drop_up1.00%$8.56
Market Cap$764.35B
Price$565.33
Perf. (24h)
arrow_drop_up0.17%$0.98
Market Cap$519.41B
Price$154.69
Perf. (24h)
arrow_drop_down0.46%-$0.73
Market Cap$374.04B
Price$125.77
Perf. (24h)
arrow_drop_up1.22%$1.52
Market Cap$314.70B

About Royalty Pharma PLC (RPRX)

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Pablo Gerardo Legorreta
Headquarters
New York
Employees
0
Exchange
NASDAQ
add Royalty Pharma PLC to watchlist

Keep an eye on Royalty Pharma PLC

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is Royalty Pharma PLC's (RPRX) price per share?

The current price per share for Royalty Pharma PLC (RPRX) is $28.14. The stock has seen a price change of -$0.19 recently, indicating a -0.67% change. This reflects the stock's recent market performance and investor sentiment.

help
What is the 52-week high and low for Royalty Pharma PLC (RPRX)?

For Royalty Pharma PLC (RPRX), the 52-week high is $31.66, which is 12.49% from the current price. The 52-week low is $25.2, the current price is 11.67% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help
Is Royalty Pharma PLC (RPRX) a growth stock?

Royalty Pharma PLC (RPRX) has shown an average price growth of 0.41% over the past three years. It has received a score of 32 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Royalty Pharma PLC as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help
What is Royalty Pharma PLC (RPRX) stock price performance year to date (YTD)?

As of the latest data, Royalty Pharma PLC (RPRX) has a year-to-date price change of -0.46%. Over the past month, the stock has experienced a price change of 5.67%. Over the last three months, the change has been -0.07%. Over the past six months, the figure is -3.2%.

help
Is Royalty Pharma PLC (RPRX) a profitable company?

Royalty Pharma PLC (RPRX) has a net income of $1.13B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 76.19% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -12.99% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $2.35B, with a revenue growth rate of 5.24%, providing insight into the company's sales performance and growth. The gross profit is $1.79B. Operating income is noted at $1.49B. Furthermore, the EBITDA is $1.57B.

help
What is the market capitalization of Royalty Pharma PLC (RPRX)?

Royalty Pharma PLC (RPRX) has a market capitalization of $16.98B. The average daily trading volume is 2.33M, indicating the stock's liquidity and investor engagement.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level